Your browser doesn't support javascript.
loading
Bone modifying agents for bone loss in patients with aromatase inhibitor as adjuvant treatment for breast cancer; insights from a network meta-analysis.
Miyashita, Hirotaka; Satoi, Sera; Kuno, Toshiki; Cruz, Christina; Malamud, Stephen; Kim, Se-Min.
Afiliación
  • Miyashita H; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA. Hirotaka.Miyashita@mountsinai.org.
  • Satoi S; Mount Sinai Bone Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Hirotaka.Miyashita@mountsinai.org.
  • Kuno T; Department of Medicine, Nippon Medical School Hospital, Tokyo, Japan.
  • Cruz C; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA.
  • Malamud S; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA.
  • Kim SM; Mount Sinai Beth Israel Comprehensive Cancer Center, New York, NY, USA.
Breast Cancer Res Treat ; 181(2): 279-289, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32318956

Texto completo: 1 Colección: 01-internacional Asunto principal: Osteoporosis / Neoplasias de la Mama / Densidad Ósea / Inhibidores de la Aromatasa / Conservadores de la Densidad Ósea Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Asunto principal: Osteoporosis / Neoplasias de la Mama / Densidad Ósea / Inhibidores de la Aromatasa / Conservadores de la Densidad Ósea Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos